Psychometric Evaluation of the Chinese Version of the Resilience Scale-10 for Cancer Children
NCT ID: NCT03544190
Last Updated: 2021-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
186 participants
OBSERVATIONAL
2018-02-28
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Needs Assessment to Guide the Development of a Paediatric Survivorship Programme in Hong Kong
NCT05355779
Cross-sectional Study of Sleep Disturbance in Hong Kong Children With Cancer Comparing With Healthy Counterparts and Children With Other Chronic Diseases
NCT07122921
the Quality of Life Assessment of Lung Cancer Patients in China
NCT01914120
Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment
NCT05205226
Mindfulness-Oriented Respiratory Distress Symptom Intervention for Lung Cancer
NCT07281300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Numerous studies indicated that resilience effectively prevents the development of mental health problems and is associated with positive mental health outcomes in children and adolescents, such as reduced levels of anxiety, depression and obsessive compulsive symptoms. Assessing resilience in children with cancer is therefore crucial for a thorough understanding of their responses to stress and adversity, which is an essential prerequisite for the design of an appropriate psychological intervention to enhance their resilience and foster the development of their coping mechanisms and positive mental well-being.
This study aims to translate the original English version of Resilience Scale for Children (RS10) into traditional Chinese. It will then test the psychometric properties of the newly translated RS10. In addition, the factorial structure of RS10 will be examined using confirmatory factor analysis (CFA).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. diagnosed with cancer within the previous 6 months and currently undergoing active treatments;
3. able to speak Cantonese and read Chinese.
Exclusion Criteria
7 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oi Kwan Joyce Chung, Dr
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Hong Kong
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chung JOK, Li WHC, Wei X, Cheung AT, Ho LLK, Chan GC. Translation and psychometric evaluation of the Chinese version of the resilience scale for children with cancer. Health Qual Life Outcomes. 2021 Oct 2;19(1):232. doi: 10.1186/s12955-021-01865-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UW18-012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.